Cargando…

Pneumococcal vaccination in times of COVID-19()

Detalles Bibliográficos
Autor principal:	Vila Córcoles, Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2022
Materias:	Editorial Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069305/ https://www.ncbi.nlm.nih.gov/pubmed/35530263 http://dx.doi.org/10.1016/j.medcle.2022.01.004

Ejemplares similares

Vacunación antineumocócica en tiempos de COVID-19
por: Vila Córcoles, Ángel
Publicado: (2022)

Indicadores pronósticos de la COVID-19 en atención primaria
por: Satué Gracia, Eva María, et al.
Publicado: (2022)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
por: Vila-Córcoles, Angel, et al.
Publicado: (2006)

Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017
por: Vila-Córcoles, Angel, et al.
Publicado: (2019)

Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Pneumococcal Vaccines: Challenges and Prospects
por: Licciardi, Paul, et al.
Publicado: (2019)

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
por: Vila-Corcoles, Angel, et al.
Publicado: (2012)

Recent Trends in Invasive Pneumococcal Disease in Korea in the Post-pneumococcal Vaccine Era
por: Huh, Hee Jae, et al.
Publicado: (2023)

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018
por: Vila-Córcoles, Angel, et al.
Publicado: (2023)

State of the Globe: Effect of Pneumococcal Conjugate Vaccines on Nonvaccine-type Invasive Pneumococcal Disease
por: Raina, Sunil Kumar
Publicado: (2019)

Conjugate Pneumococcal Vaccines: Need and Choice in India
por: Malik, Akash, et al.
Publicado: (2013)

Current Recommendations for Pneumococcal Vaccination of Children and Adults
por: Fakhraei, Hossein, et al.
Publicado: (2015)

Pneumococcal vaccination and childhood pneumonia in South Africa
por: Mulholland, Kim, et al.
Publicado: (2015)

Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?
por: McDaniel, Larry S., et al.
Publicado: (2016)

Influenza and Pneumococcal Vaccination in Coronary Artery Disease
por: Matoba, Tetsuya
Publicado: (2021)

Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study
por: Ochoa-Gondar, Olga, et al.
Publicado: (2023)

Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study
por: Vila-Corcoles, Angel, et al.
Publicado: (2018)

Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study
por: Ochoa-Gondar, O., et al.
Publicado: (2017)

Optimizing the benefits of pneumococcal vaccination in the Kingdom of Saudi Arabia
por: Azhar, Esam I., et al.
Publicado: (2016)

Pneumococcal conjugate vaccines: choice of schedule and product development
por: Lee, Jin
Publicado: (2020)

Personalizing pneumococcal vaccination recommendations: The Saudi Thoracic Society guidelines
por: Torres, Antoni
Publicado: (2016)

Higher valent Pneumococcal Conjugate Vaccines: is it a roller coaster?
por: Oligbu, Godwin
Publicado: (2020)

Clinical practice guidelines for influenza and pneumococcal vaccination: The Indian perspective
por: Koul, Parvaiz A
Publicado: (2020)

COVID-19 vaccines: no time for complacency
por: The Lancet
Publicado: (2020)

Does pneumococcal vaccination prevent myocardial infarction and stroke in elderly adults?
por: Søgaard, Ole S
Publicado: (2015)

Pneumococcal pneumonia
por: Goldblatt, David, et al.
Publicado: (2020)

Promising Expectations for Pneumococcal Vaccination during COVID-19
por: Im, Hyobin, et al.
Publicado: (2021)

The prevention of pneumococcal infections
por: Chang, Mee Soo, et al.
Publicado: (2016)

COVID‐19 vaccination, time for a second breath?
por: Gerke, Christiane E, et al.
Publicado: (2022)

COVID-19 vaccines: A race against time
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Immunization with Attenuated Pneumococcal Strains Provides Protection against Pneumococcal Colonization in Humans
por: Narciso, Ana Rita, et al.
Publicado: (2023)

Influenza and pneumococcal vaccination and COVID-19 in kidney transplant patients
por: Satir, Atilla, et al.
Publicado: (2022)

Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings
por: Vila-Corcoles, Angel, et al.
Publicado: (2021)

Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore
por: Lim, Rachel HF, et al.
Publicado: (2020)

Providing Pneumococcal Vaccines Reduces the Risk of Serious Infections From Pneumococcal Pneumonia. We Should Consider a Simplified Immunization Schedule
por: Almasry, Mazen, et al.
Publicado: (2023)

Pneumococcal disease and use of pneumococcal vaccines in Taiwan
por: Wei, Sung-Hsi, et al.
Publicado: (2015)

The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan
por: Komori, Akira, et al.
Publicado: (2021)

An Experimental Human Colonization Model with Pneumococcal Serotype 3 has the Potential to be Used for Vaccine Studies
por: Henriques-Normark, Birgitta, et al.
Publicado: (2022)

The impact of COVID-19 on routine vaccinations in Taiwan and an unexpected surge of pneumococcal vaccination
por: Chiu, Nan-Chang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_20humg2u2mtc694hi9c4ra74n6